- Home
- VRNA vs BATRA Comparison
VRNA vs BATRA Comparison
Compare VRNA & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- BATRA
- Stock Information
- Founded
- VRNA 2005
- BATRA 1991
- Country
- VRNA United Kingdom
- BATRA United States
- Employees
- VRNA N/A
- BATRA N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- BATRA Broadcasting
- Sector
- VRNA Health Care
- BATRA Industrials
- Exchange
- VRNA Nasdaq
- BATRA Nasdaq
- Market Cap
- VRNA 3.2B
- BATRA 2.6B
- IPO Year
- VRNA 2017
- BATRA N/A
- Fundamental
- Price
- VRNA $43.06
- BATRA $41.41
- Analyst Decision
- VRNA Strong Buy
- BATRA Strong Buy
- Analyst Count
- VRNA 6
- BATRA 2
- Target Price
- VRNA $43.83
- BATRA $53.50
- AVG Volume (30 Days)
- VRNA 1.0M
- BATRA 37.2K
- Earning Date
- VRNA 11-04-2024
- BATRA 11-06-2024
- Dividend Yield
- VRNA N/A
- BATRA N/A
- EPS Growth
- VRNA N/A
- BATRA N/A
- EPS
- VRNA N/A
- BATRA N/A
- Revenue
- VRNA $5,624,000.00
- BATRA $678,378,000.00
- Revenue This Year
- VRNA N/A
- BATRA $10.38
- Revenue Next Year
- VRNA $644.06
- BATRA $5.23
- P/E Ratio
- VRNA N/A
- BATRA N/A
- Revenue Growth
- VRNA 1127.95
- BATRA 5.31
- 52 Week Low
- VRNA $11.39
- BATRA $39.67
- 52 Week High
- VRNA $43.73
- BATRA $46.65
- Technical
- Relative Strength Index (RSI)
- VRNA 61.99
- BATRA 44.27
- Support Level
- VRNA $38.77
- BATRA $40.92
- Resistance Level
- VRNA $43.73
- BATRA $41.84
- Average True Range (ATR)
- VRNA 1.41
- BATRA 0.66
- MACD
- VRNA 0.07
- BATRA -0.03
- Stochastic Oscillator
- VRNA 60.80
- BATRA 27.12
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About BATRA Atlanta Braves Holdings Inc. Series A
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include, baseball which generates key revenue, and mixed-use development.